SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
20848200
Source:
http://linkedlifedata.com/resource/pubmed/id/20848200
Search
Subject
(
60
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0001792
,
umls-concept:C0021311
,
umls-concept:C0030705
,
umls-concept:C0035525
,
umls-concept:C0087111
,
umls-concept:C0205191
,
umls-concept:C0220847
,
umls-concept:C0439234
,
umls-concept:C0683956
,
umls-concept:C0871261
,
umls-concept:C1704632
,
umls-concept:C1706817
,
umls-concept:C2911692
pubmed:issue
11
pubmed:dateCreated
2010-10-21
pubmed:abstractText
Elderly patients with chronic hepatitis C virus (HCV) infection represent an understudied population, and little is known regarding the predictive factors for sustained virological response (SVR) to antiviral therapy in these patients.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7902782
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha
,
http://linkedlifedata.com/resource/pubmed/chemical/Polyethylene Glycols
,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
,
http://linkedlifedata.com/resource/pubmed/chemical/Ribavirin
,
http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2a
,
http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2b
,
http://linkedlifedata.com/resource/pubmed/chemical/peginterferon alfa-2a
,
http://linkedlifedata.com/resource/pubmed/chemical/peginterferon alfa-2b
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1573-2568
pubmed:author
pubmed-author:BassoMonicaM
,
pubmed-author:GianniniEdoardo GEG
,
pubmed-author:PicciottoAntoninoA
,
pubmed-author:SavarinoVincenzoV
pubmed:issnType
Electronic
pubmed:volume
55
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3193-9
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:20848200-Aged
,
pubmed-meshheading:20848200-Antiviral Agents
,
pubmed-meshheading:20848200-Female
,
pubmed-meshheading:20848200-Hepatitis C, Chronic
,
pubmed-meshheading:20848200-Humans
,
pubmed-meshheading:20848200-Intention to Treat Analysis
,
pubmed-meshheading:20848200-Interferon-alpha
,
pubmed-meshheading:20848200-Male
,
pubmed-meshheading:20848200-Polyethylene Glycols
,
pubmed-meshheading:20848200-Prospective Studies
,
pubmed-meshheading:20848200-Recombinant Proteins
,
pubmed-meshheading:20848200-Ribavirin
,
pubmed-meshheading:20848200-Treatment Outcome
,
pubmed-meshheading:20848200-Viral Load
pubmed:year
2010
pubmed:articleTitle
Predictive factors for response to peginterferon-alpha and ribavirin treatment of chronic HCV infection in patients aged 65 years and more.
pubmed:affiliation
Gastroenterology Unit, Department of Internal Medicine, University of Genoa, Viale Benedetto XV no. 6, Genoa, Italy. egiannini@unige.it
pubmed:publicationType
Journal Article